Doug Roach Email

VP Commercialization . Sera Prognostics

Current Roles

Employees:
77
Revenue:
$20.3M
About
In collaboration with the National Institutes of Health Maternal Fetal Medicine Network, Sera's scientific cofounders, Steven W. Graves, Ph.D., a professor in the department of Chemistry and Biochemistry at Brigham Young University and M. Sean Esplin, M.D., an associate professor and high-risk obstetrician at the University of Utah School of Medicine, identified biomarkers detectable from simple blood tests that can help predict the likelihood of preterm delivery and other pregnancy complications. Sera Prognostics has exclusively licensed rights to the preterm birth and preeclampsia biomarkers and the proteomics discovery technology for use in developing diagnostics to help predict and manage pregnancy complications.
Sera Prognostics Address
2749 East Parleys Way
Millcreek, UT
United States

Past Companies

Sera PrognosticsVice President of Commercialization
Sera PrognosticsVice President Marketing & Commercial Operations at Sera Prognostics
Sera PrognosticsSenior Director, National Sales and Product Development, US

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.